A model of coincident Aβ plaque and NP tau has recently been described [19] in which plaque-forming Tg mice (e.g., 5XFAD [31] or APP-knock-in [34]) develop widespread NP tau in the absence of tau overexpression after the intracerebral injection of a small amount of AD-tau. Here, MAPT is linked to Alzheimer disease.